Key result
Novel nomogram predicts 1-year overall survival with ~82% accuracy in renal cell carcinoma.
Why the study?
Venous tumor thrombus in non-metastatic renal cancer is associated with poor prognosis and short natural course, necessitating investigation of surgical efficacy and prognostic factors.
What are the prognostic factors and overall survival in non-metastatic renal cancer patients with venous tumor thrombus undergoing surgical treatment?
Cohort (n=114)
What are the prognostic factors and overall survival in non-metastatic renal cancer patients with venous tumor thrombus undergoing surgical treatment?
In non-metastatic renal cancer patients with venous tumor thrombus, surgical treatment yields a 5-year overall survival of 43.8%, and a nomogram incorporating tumor diameter, LDH, and neutrophils can help predict prognosis.
Answers are grounded in this paper and cite their sources.
Surgery was associated with favorable survival in non-metastatic renal cancer with VTT; nomogram extends Mayo grading but leaves open prospective validation.
Background: Venous system invasion is a prominent characteristic of local progression in renal cancer and treatment-naïve renal cancer patients with venous tumor thrombus (VTT) gained short natural course and poor prognosis. This study aimed to investigate the efficacy of the surgery and prognostic factors in non-metastatic renal cancer patients with VTT and to construct a nomogram prognostic model. Methods: Clinical data of 114 non-metastatic renal cancer patients with VTT who underwent surgical treatment from January 2011 to September 2022 were retrospectively analyzed. In order to find independent risk factors of prognosis, survival analysis was performed via univariate and multivariate Cox regression models and Kaplan-Meier method. Nomogram prognostic model was established to calculate patients' risk scores. Receiver operating characteristic curve and decision curve analysis were conducted to evaluate the efficacy of the prognostic model. Results: A total of 114 patients were included in this study and there were 48, 12, 25, 23, and 6 cases of grade 0-IV VTT. No perioperative death occurred. The 3-year probabilities of overall survival (OS) and 5-year probabilities of OS were 67% and 43.8%, respectively. Multivariate Cox regression analysis revealed that kidney tumor diameter, preoperative lactate dehydrogenase (LDH), and preoperative neutrophils were independent risk factors. Nomogram was constructed to predict prognosis in renal cancer patients with VTT based on above indicators and Mayo VTT grading. The area under the ROC curve of 1-, 2-, 3-, and 5-year OS of the patients were 0.82, 0.67, 0.57, and 0.55 respectively. Conclusions: Surgical treatment enables renal cancer patients with VTT to gain a better prognosis. Kidney tumor diameter, preoperative LDH, and preoperative neutrophils were independent risk factors. The nomogram perfects the Mayo grading, and provides a reliable reference for evaluation of prognosis of renal cancer patients with VTT.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2023) conducted a cohort in non-metastatic renal cancer with venous tumor thrombus (n=114). Surgical treatment was evaluated on overall survival (OS). A prognostic nomogram incorporating kidney tumor diameter, preoperative LDH, preoperative neutrophils, and Mayo VTT grading predicted 1-year overall survival with an AUC of 0.82.
Synapse has enriched 10 related papers. Consider them for comparative context: